Fueling the Tumor Microenvironment with Cancer-Associated Adipocytes.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
14 04 2023
Historique:
received: 14 02 2023
accepted: 16 02 2023
medline: 17 4 2023
entrez: 14 4 2023
pubmed: 15 4 2023
Statut: ppublish

Résumé

Despite their abundance throughout the body, adipocytes are often ignored for their contributions within the tumor microenvironment (TME). However, their role in fueling cancer is becoming increasingly apparent as interest in the TME has seen remarkable advances in recent years. A seminal study by Dirat and colleagues highlighted the essential impact of the peritumoral adipose tissue in breast cancer progression and was among the first to demonstrate that tumor cells can reprogram adipocytes within their immediate niche to adopt unique characteristics. These "cancer-associated adipocytes" (CAA) were found to exchange cytokines and lipids with tumor cells, leading to their metabolic rewiring and acquisition of proinflammatory and invasive phenotypes. These important discoveries have represented a breakthrough in understanding the bidirectional metabolic dialog between adipocytes and tumor cells, and have contributed renewed perspectives on the functional contributions of adipocytes within the TME. Moreover, the effects of CAA may be further amplified in the setting of obesity as lipids dramatically accumulate, providing insights into the link between breast cancer and its more advanced clinical state in obese conditions. Thus, the different molecular actors involved in the dialog between tumor cells and CAA represent promising therapeutic targets that may have particular relevance in improving prognosis in obese patients with cancer. See related article by Dirat and colleagues, Cancer Res 2011;71:2455-65.

Identifiants

pubmed: 37057599
pii: 725105
doi: 10.1158/0008-5472.CAN-23-0505
doi:

Substances chimiques

Lipids 0

Types de publication

Editorial Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1170-1172

Commentaires et corrections

Type : CommentOn

Informations de copyright

©2023 American Association for Cancer Research.

Auteurs

Caroline Bouche (C)

Institut de Pharmacologie et de Biologie Structurale, CNRS/Université de Toulouse UMR 5089, Toulouse, France.
Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Department of Physiology, McGill University, Montreal, Quebec, Canada.
Département de Chirurgie Gynécologique oncologique, CHU-Toulouse, Institut universitaire du cancer de Toulouse-Oncopole, Toulouse, France.

Daniela F Quail (DF)

Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Department of Physiology, McGill University, Montreal, Quebec, Canada.
Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH